Skip to main content
MREO logo

MREO · Mereo BioPharma Group plc · Proposed Sales

Track MREO — free
$0.30 +0.01 (+4.16%) At close · Nov 4
Market Cap
$46.47M
Shares
159.69M
Volume · Nov 4 526.05K Avg daily vol (3M) 3.9M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2024-09-12 Fox Christine Ann 28,286
2024-09-12 Alexandra Hughes-Wilson 148,110
2024-09-12 Lewicki John A. 16,149
2024-09-12 Scots-Knight Denise 88,657
2024-09-12 Sermon Charles 30,926
2024-08-22 Deepika Pakianathan 105,244
2024-06-20 Lewicki John A. 26,647
2024-06-20 Scots-Knight Denise 146,284
2024-06-20 Sermon Charles 51,028
2024-06-20 Alexandra Hughes-Wilson 33,102
2024-06-20 Fox Christine Ann 46,672
2024-05-23 Alexandra Hughes-Wilson 100,432
Showing 1–12 of 12 filings
Key facts CIK 1719714 CUSIP 589492107 13F (30d) 9 filings 9 filers Visit website Investor relations